Global Polymer Biomaterial Market 2024 , Forecast To 2033
7 Mar, 2024
The polymer biomaterial market has experienced rapid growth in recent years, expanding from $66.45 billion in 2023 to $79.06 billion in 2024, with a compound annual growth rate (CAGR) of 19.0%. This growth can be attributed to factors such as increasing demand for medical devices and growing awareness of the benefits of polymer biomaterials. Looking ahead, the market is anticipated to continue its rapid expansion, reaching $146.61 billion in 2028 at a CAGR of 16.7%. Factors contributing to this growth may include customized medicine, regenerative medicine, and advancements in 3D printing. Major trends in this period could include advanced drug delivery, bioresorbable polymers, and nanotechnology integration.
Global Polymer Biomaterial Market Key Driver
Increasing applications of polymeric biomaterials in tissue engineering are driving the global polymer biomaterials market (1). Polymers are extensively used in regenerative medicine and tissue engineering due to their flexibility and versatile properties such as tailoring the damaged tissue's physical, chemical, and mechanical properties by modification of functional groups during synthesis, according to the regeneration capability of tissues of the organs (2). Besides being biodegradable, they offer different geometry and structures, thus meeting the needs of specific tissue engineering applications. These growing applications of polymer biomaterial in tissue engineering are expected to drive the market in the forecast period (3).
Get A Free Sample Of The Global Polymer Biomaterial Market ReportGlobal Polymer Biomaterial Market Segments
The polymer biomaterial market covered in this report is segmented –
1) By Type: Nylon, Silicone Rubber, Polyester, Polymethyl Methacrylate (PMMA), Polyethylene (PE), Polyvinyl Chloride, Other Types
2) By Nature: Natural, Synthetic
3) By Application: Cardiovascular, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Orthopedics, Neurological Disorders / Central Nervous System, Other Applications
By Geography: The countries covered in the polymer biomaterial market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the polymer biomaterials market in 2023. Western Europe was the second-largest region in the global polymer biomaterials market report. The regions covered in the polymer biomaterial market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Major Polymer Biomaterial Industry Players
BASF SE; Corbion N.V.; Zimmer Biomet Holdings Inc.; Royal DSM N.V.; Koninklijke DSM N.V.; Covestro AG; Evonik Industries AG; Starch Medical Inc.; Victrex plc; W. L. Gore and Associates Inc.; Bayer AG; DSM Biomedical B.V.; Purac Biomaterials; Ticona LLC; Invibo LLC; Covalon Technologies Ltd.; Osteotech Inc.; Medtronic plc; Stryker Corporation; Synthes Inc.; Mitsui & Co. Ltd.; Polyfibre Industries Pte Ltd.; Toray Industries Inc.; Stein Fibers Ltd.; Diyou Fiber Corporation; Bezwada Biomedical LLC; Collagen Solutions plc; Cam Bioceramics B.V.; CeramTec GmbH; Gelita AG; AorTech Biomaterials Pty Ltd.; Berkeley Advanced Biomaterials Inc.; Biocomposites Ltd.; BioHorizons IPH Inc.; Biomerics LLC; Bioteque Corporation; Carpenter Technology Corporation; CollPlant Holdings Ltd.; CoorsTek Inc.; EndoShape Inc.; Heraeus Medical Components LLC; Kyocera Corporation; PolyNovo Biomaterials Pty Ltd.; Secant Group LLC
Get The Full Global Polymer Biomaterial Market ReportPolymer Biomaterial Market Overview
Polymer biomaterials are inert pharmacological substances made up of natural and synthetic origin. Polymer biomaterials are used for enhancing the functionality of tissues and organs that are damaged in various disease therapies.